Sandrock Alfred 4

What Happened

• Alfred Sandrock, President & CEO and Director of Voyager Therapeutics (VYGR), sold 11,732 shares on Feb 18, 2026. The weighted-average sale price was $3.41 per share (prices ranged $3.35–$3.47), for total proceeds of about $40,006. The sale was a disposition (S) effected under a pre-existing durable automatic sale instruction to satisfy tax withholding related to RSUs that vested on Feb 17, 2026 — not a discretionary trade by the insider.

Key Details

• Transaction date: 2026-02-18; Form 4 filed: 2026-02-20 (timely)
• Shares sold: 11,732; weighted-average price: $3.41; price range: $3.35–$3.47
• Total value reported: ~$40,006
• Reason/footnote: Sell-to-cover automatic sale to satisfy tax withholding on vested restricted stock units (F1); sales occurred in multiple transactions (F2)
• Shares owned after transaction: not specified in the provided filing excerpt
• Exhibit included: 24.1 Limited Power of Attorney

Context

• This was a routine sell-to-cover transaction tied to RSU vesting (tax withholding), which insiders commonly use and which does not necessarily indicate a change in sentiment. The filing indicates the sales were automatic and non-discretionary.